Clinical Trial Details
| Trial ID: | L3528 |
| Source ID: | NCT00747968 |
| Associated Drug: | Byetta, Exenatide |
| Title: | The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: Byetta, Exenatide |
| Outcome Measures: | Primary: steady glucose metabolism in the heart and brain during hyperglycemia with GLP-1-analogue infusion compared to placebo., oct. 2008 - oct 2010 | |
| Sponsor/Collaborators: | Sponsor: University of Aarhus | Collaborators: Eli Lilly and Company|Aarhus University Hospital |
| Gender: | MALE |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2|PHASE3 |
| Enrollment: | 8 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE |
| Start Date: | 2010-02 |
| Completion Date: | 2011-03 |
| Results First Posted: | |
| Last Update Posted: | 2011-06-30 |
| Locations: | Aarhus University Hospital, Investigational Dept. M of Endocrinology, Aarhus, Aarhus C, 8000, Denmark|Aarhus University Hospital, Investigational Dept. M of Endocrinology, Aarhus, 8000 C, Denmark|Aarhus University Hospital, Investigational Dept. M of Endocrinology, Aarhus, 8000, Denmark |
| URL: | https://clinicaltrials.gov/show/NCT00747968 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|